Sarcopenia Treatment Market Worldwide Players to Witness Exponential Growth in Healthcare Sector During Post-Pandemic Period | Abbott laboratories, Inc., Nestle S.A., Pfizer, Inc., Novartis AG, Sanofi, Inc.

📌 Overview of the Sarcopenia Treatment Market:

The phenotype of sarcopenia is complex, with genetic and environmental factors all playing a role. While the specific causes and progression of sarcopenia remain largely unclear, there is an association between sarcopenia and a high risk of fall accidents. The severity of the condition is also highly dependent on comorbid conditions such as diabetes and hypertension. The primary cause of sarcopenia is aging.

Growing incidences of vitamin D deficiency is a prime factor driving growth of the sarcopenia treatment market. According to the U.S. National Library of Medicine, vitamin D deficiency is prevalent worldwide. The prevalence of Vitamin D deficiency ranged from 40% to 99%, with most of the studies reporting a prevalence of 80%–90%. It was prevalent in all the age groups and high-risk groups alike. Increasing consumption of nutrition and dietary supplementt in order to cope up with the condition is again fostering growth of the market. Rise is aging population is another key factor increasing prevalence of sarcopenia which in turn accelerating market growth.

Purchase the Complete Sarcopenia Treatment Market Research Report at https://www.stratagemmarketinsights.com/cart/42745

North America is expected to witness significant growth over the forecast period owing to the increasing aging population in the region. According to U.S. Census Bureau, there were 40.3M U.S. residents 65 years and older in the 2010 Census and 54.1M in the July 1, 2019, population estimates.

📌 Key Developments:

❖ In January 2022, MyMD Pharmaceuticals, Inc. a pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. Patent and Trademark Office (USPTO) awarded to the company U.S. Patent 11,219,620 B2, titled “Method of Treating Sarcopenia.”

❖ In February 2021, MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company announced that it has been granted United States Patent #10,925,904 by the United States Patent and Trademark Office (USPTO) for improving skeletal muscle protein synthetic rate in older mammals through the administration of proprietary nutritional compositions such as MYOS' advanced nutrition product, Fortetropin

❖ In October 2021, Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its chronic sarcopenia treatment for healthy aging

❖ In August 2021, Biophytis SA announces the top line results of the SARA-INT phase 2 clinical study with Sarconeos (BIO101) in Sarcopenia.

📌 The Leading Players involved in the global Sarcopenia Treatment market are:

❖ Abbott laboratories, Inc.
❖ American Way (Amway) Corporation
❖ Bayer AG
❖ GlaxoSmithKline plc.
❖ Nestle S.A.
❖ Pfizer, Inc.
❖ Novartis AG
❖ Sanofi, Inc.
❖ Zydus Cadila, Ltd
❖ F-Hoffmann La-Roche

📌 The Study Explore the Product/Types of the Market:

❖ Protein Supplements
❖ Vitamin B12 Supplements
❖ Vitamin D & Calcium Supplements
❖ Others

📌 Key Applications/End-users of the Market:

❖ Hospital Pharmacies
❖ Drug Stores & Retail Pharmacies
❖ Online Pharmacies

📌 Regions/Country Included are:

❖ The Middle East and Africa (Turkey, GCC Countries, Egypt, South Africa)
❖ North America( United States, Mexico, and Canada)
❖ South America (Brazil, etc.)
❖ Europe (Germany, Russia, UK, Italy, France, etc.)
❖ Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

In the latest industry analysis by Stratagem Market Insights (SMI), the growth of the Sarcopenia Treatment market is projected to expand at a driving CAGR through 2028 as the global market grows gradually recovers. The report aims to provide insight into hidden growth opportunities and challenges. It also provides recommendations for businesses to prepare for unexpected problems. This newly published insightful report sheds light on the market insights of the Sarcopenia Treatment, its key dynamics, its impact across the value chain from suppliers/service providers to end-users, and the growth of the Sarcopenia Treatment market.

To remain ‘ahead’ of your competitors, request a sample @ https://www.stratagemmarketinsights.com/sample/42745

The study provides pragmatic and valuable market insights into the Sarcopenia Treatment. Additionally, the latest report offers details on the current scenario of the market across different regions along with historical data and forecasts (2022-2028) of the market. The report also includes information on sales and demand for the Sarcopenia Treatment market across various industries and regions.

The research conducted by SMI provides exclusive information on how the market is growing. The study identifies essential trends determining the growth of the Sarcopenia Treatment market. This newly published report sheds light on vital dynamics such as drivers, restraints, and opportunities of leading market players as well as emerging players associated with the production/services and supply.

📌 Report Benefits & Key Questions Answered:

✔ Sarcopenia Treatment Market Companies and Share Analysis: The report offers a detailed Sarcopenia Treatment market share analysis to estimate the market proportions covered by Tier 1, Tier 2, and Tier3 companies.

✔ Sarcopenia Treatment Market Historical Volume Analysis: The report provides a comparative analysis of the Sarcopenia Treatment's historical sales and 2022-2028 forecasted sales performance.

✔ Sarcopenia Treatment market Category and Segment Level Analysis: SMI provides a comprehensive analysis of the factors enabling revenue growth across key segments. It highlights key growth drivers and provides valuable information to understand sales prospects at local and regional levels.

✔ Sarcopenia Treatment Consumption by Demographics: The report studies consumer behavior and consumption patterns to provide informed recommendations. Demographic analysis is intended to help businesses better understand consumer preferences and design products/services and market strategies around them.

✔ Post-COVID Consumer Spending for Sarcopenia Treatment: Market research carefully examines consumer spending behavior post-COVID-19. It measures how general trends influence their behavior and subsequently their spending power.

Purchase this exclusive report to access full information @ https://www.stratagemmarketinsights.com/cart/42745

📌 Reasons why you should buy this report:

➥ Understand the Current and future of the Sarcopenia Treatment Market in both Established and emerging markets.
➥ The report assists in relocating the business strategies by accentuating the Sarcopenia Treatment business priorities.
➥ The report throws light on the segment anticipated to dominate the Sarcopenia Treatment industry and market.
➥ Forecasts the regions expected to perceive ascension.
➥ The newest developments within the Sarcopenia Treatment industry and details of the industry leaders alongside their market share and methods.
➥ Saves time on the entry-level research as the report contains significant data concentrating growth, size, key players, and segments of the industry.
➥ Save time carrying out entry-level research by characterizing the growth, size, major players, and segments within the Global Market.

In addition, the following years are taken into account for the study:
Historic year - 2015-2020
Base year - 2021
Forecast period ** - 2022-2028 [** unless otherwise stated]

** It also includes a detailed analysis of the competitive landscape, the opportunities available in the micro-market that stakeholders can invest in, and the product services of key players.

Contact Us:

Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com
SJ

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide.

This release was published on openPR.